BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology. Int Immunopharmacol 2021;90:107247. [PMID: 33307513 DOI: 10.1016/j.intimp.2020.107247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Azhdari Tehrani H, Ramezaninejad S, Mardani M, Shokouhi S, Darnahal M, Hakamifard A. Hematologic malignancies and COVID‐19 infection: A monocenter retrospective study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.638] [Reference Citation Analysis]
2 Johnson BD, Zhu Z, Lequio M, Powers CGD, Bai Q, Xiao H, Fajardo E, Wakefield MR, Fang Y. SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone. Med Oncol 2022;39. [DOI: 10.1007/s12032-021-01628-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kanduc D. From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity. Glob Med Genet 2021;8:176-82. [PMID: 34877576 DOI: 10.1055/s-0041-1735590] [Reference Citation Analysis]
4 Wu D, Rao Q, Zhang W. The natural course of COVID-19 patients without clinical intervention. J Med Virol 2021;93:5527-37. [PMID: 33990975 DOI: 10.1002/jmv.27087] [Reference Citation Analysis]
5 Moshfeghi R, Toghraie D. An analytical and statistical review of selected researches in the field of estimation of rheological behavior of nanofluids. Powder Technology 2022;398:117076. [DOI: 10.1016/j.powtec.2021.117076] [Reference Citation Analysis]
6 Haque S, Cook K, Sahay G, Sun C. RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer. Pharmaceutics 2021;13:1694. [PMID: 34683988 DOI: 10.3390/pharmaceutics13101694] [Reference Citation Analysis]
7 He Y, Ding Y, Cao B, Huang Y, Wang X. COVID-19 vaccine development from the perspective of cancer patients. Hum Vaccin Immunother 2021;17:3281-7. [PMID: 34170788 DOI: 10.1080/21645515.2021.1943988] [Reference Citation Analysis]
8 Shapiro RS. COVID-19 vaccines and nanomedicine. Int J Dermatol 2021;60:1047-52. [PMID: 34089534 DOI: 10.1111/ijd.15673] [Reference Citation Analysis]
9 García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021;9:433. [PMID: 33925526 DOI: 10.3390/vaccines9050433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
10 Spadaccini M, Canziani L, Aghemo A, Lleo A, Maselli R, Anderloni A, Carrara S, Fugazza A, Pellegatta G, Galtieri PA, Hassan C, Greenwald D, Pochapin M, Wallace M, Sharma P, Roesch T, Bhandari P, Emura F, Raju GS, Repici A. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective. United European Gastroenterol J 2021. [PMID: 34102015 DOI: 10.1002/ueg2.12103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tavares JL, Cavalcanti IDL, Santos Magalhães NS, Lira Nogueira MCDB. Nanotechnology and COVID-19: quo vadis? J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05452-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Panou E, Nikolaou V, Marinos L, Kallambou S, Sidiropoulou P, Gerochristou M, Stratigos A. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34628691 DOI: 10.1111/jdv.17736] [Reference Citation Analysis]
13 Ahmad Malik J, Ahmed S, Shinde M, Hajjaj Saeid Al-marmash M, Alghamdi S, Hussain A, Anwar S. The impact of COVID-19 on the comorbidities: A review of recent updates for combating it. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
14 Ullah S, Ullah F, Karras DA, Rahman W, Ahmad G, Ijaz M, Gao T. CRDB: A Centralized Cancer Research DataBase and an example use case mining correlation statistics of cancer and covid-19 (Preprint). JMIR Cancer. [DOI: 10.2196/35020] [Reference Citation Analysis]
15 Bilge M, Akilli IK, Karaayvaz EB, Yesilova A, Kart Yasar K. Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19. Infect Agent Cancer 2021;16:60. [PMID: 34526045 DOI: 10.1186/s13027-021-00400-4] [Reference Citation Analysis]
16 Mireștean CC, Crișan A, Mitrea A, Buzea C, Iancu RI, Iancu DPT. New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era. J Clin Med 2021;10:587. [PMID: 33557273 DOI: 10.3390/jcm10040587] [Reference Citation Analysis]
17 Dennis LK, Hsu CH, Arrington AK. Reduction in Standard Cancer Screening in 2020 throughout the U.S. Cancers (Basel) 2021;13:5918. [PMID: 34885028 DOI: 10.3390/cancers13235918] [Reference Citation Analysis]
18 Sinha S, Kundu CN. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Med Oncol 2021;38:101. [PMID: 34302557 DOI: 10.1007/s12032-021-01553-3] [Reference Citation Analysis]
19 Gupta T, Debele TA, Wei YF, Gupta A, Murtaza M, Su WP. Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence. Cancers (Basel) 2022;14:213. [PMID: 35008377 DOI: 10.3390/cancers14010213] [Reference Citation Analysis]
20 Gao L, Li GS, Li JD, He J, Zhang Y, Zhou HF, Kong JL, Chen G. Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods. Comput Struct Biotechnol J 2021;19:6229-39. [PMID: 34840672 DOI: 10.1016/j.csbj.2021.11.026] [Reference Citation Analysis]
21 Manna PR, Gray ZC, Reddy PH. Healthy Immunity on Preventive Medicine for Combating COVID-19. Nutrients 2022;14:1004. [DOI: 10.3390/nu14051004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kiriacos CJ, Khedr MR, Tadros M, Youness RA. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. Front Oncol 2022;12:837408. [PMID: 35664773 DOI: 10.3389/fonc.2022.837408] [Reference Citation Analysis]
23 Liu T, Bai Y, Du M, Gao Y, Liu Y. Susceptible-Infected-Removed Mathematical Model under Deep Learning in Hospital Infection Control of Novel Coronavirus Pneumonia. J Healthc Eng 2021;2021:1535046. [PMID: 34745489 DOI: 10.1155/2021/1535046] [Reference Citation Analysis]
24 Latif MB, Shukla S, Estrada PMDR, Ribeiro SP, Sekaly RP, Sharma AA. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection. Transl Res 2021:S1931-5244(21)00284-X. [PMID: 34871809 DOI: 10.1016/j.trsl.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gutiérrez Rodelo C, Salinas RA, Armenta Jaimearmenta E, Armenta S, Galdámez-martínez A, Castillo-blum SE, Astudillo-de la Vega H, Nirmala Grace A, Aguilar-salinas CA, Gutiérrez Rodelo J, Christie G, Alsanie WF, Santana G, Thakur VK, Dutt A. Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials. Coordination Chemistry Reviews 2022;457:214402. [DOI: 10.1016/j.ccr.2021.214402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
26 Lee J, Kwon KH. Development of customized inner beauty products and customized cosmetics apps according to the use of NRF2 through DTC genetic testing after the COVID‐19 pandemic. J of Cosmetic Dermatology. [DOI: 10.1111/jocd.14467] [Reference Citation Analysis]
27 González-escamilla M, Pérez-ibave DC, Burciaga-flores CH, Ortiz-murillo VN, Ramírez-correa GA, Rodríguez-niño P, Piñeiro-retif R, Rodríguez-gutiérrez HF, Alcorta-nuñez F, González-guerrero JF, Vidal-gutiérrez O, Garza-rodríguez ML. Epidemiological Algorithm for Early Detection of COVID-19 Cases in a Mexican Oncologic Center. Healthcare 2022;10:462. [DOI: 10.3390/healthcare10030462] [Reference Citation Analysis]
28 Han Z, Zhang Y, Wang P, Tang Q, Zhang K. Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy. Brief Bioinform 2021:bbab110. [PMID: 33866350 DOI: 10.1093/bib/bbab110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Doulberis M, Papaefthymiou A, Kotronis G, Gialamprinou D, Soteriades ES, Kyriakopoulos A, Chatzimichael E, Kafafyllidou K, Liatsos C, Chatzistefanou I, Anagnostis P, Semenin V, Ntona S, Gkolia I, Papazoglou DD, Tsinonis N, Papamichos S, Kirbas H, Zikos P, Niafas D, Kountouras J. Does COVID-19 Vaccination Warrant the Classical Principle "ofelein i mi vlaptin"? Medicina (Kaunas) 2021;57:253. [PMID: 33803295 DOI: 10.3390/medicina57030253] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]